Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
coronary artery disease
MedTech
Medtronic stents net FDA OK to treat coronary artery junctions
Medtronic secured FDA approval for a technique to treat the build-up of plaques that may block the junction between two arteries feeding the heart.
Conor Hale
Sep 21, 2022 11:38am
Cleerly scores $192M for heart attack-predicting AI
Jul 25, 2022 11:51am
Abbott's imaging catheter recall hit with FDA's Class I tag
May 27, 2022 10:28am
Supply chain challenges upend Caladrius' heart drug trial
May 24, 2022 10:00am
Cleerly AI faces off with angiography in heart disease study
Feb 23, 2022 11:46am
HeartFlow exits SPAC deal due to 'unfavorable market conditions'
Feb 7, 2022 10:20am
